Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc. trades under the ticker DYNS following the completion of its de-SPAC merger with Dynamics Special Purpose Corp, a blank-check company sponsored by Foresite Capital Management that went public in 2021. The combined company operates in the biotechnology sector, focusing on synthetic biology and engineered gene-circuit therapeutics designed to treat cancer and other complex diseases. The June 2022 Form 8-K, filed under accession number 0001193125-22-169353, reflects corporate activity surrounding the closing of that business combination, marking the transition from SPAC to a publicly listed operating company. For full filing history, sponsor details, and deal analytics on DYNS and hundreds of other SPACs, create a free account at SpacDesk.